Protagonist Therapeutics Inc. (PTGX) rose 14.09% or 2.85 to $23.08. It is near to 224931 shares traded, which is 174.81% compare to the average total volume 128671. The market cap of PTGX is $472.67 million. The year to date change is -4.35%. The 52 week price range is from $8.0 to $23.75. Price of PTGX have changed -3.02% during last week. It have changed -0.69% over last month, 10.01% over last 3 months, 24.42% over last 6 months and 47.99% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 19.37. It is -16.07% below current price. The 200-day Moving Averages for PTGX is 15.86. It is -31.28% below current price. The 52-week High is 23.75. It is 2.90% from the current price. The 52-week Low is 8.0. It is -65.34% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 6.14 on 2018-02-15. Short % to float is 3.91%. There are some statistics of PTGX. It is has market cap $472.67 million. The share outstanding is 20.48 million. The average volume is 128671. The revenue is 8.78M. The percent of top 15 Institution holding is 46.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -56.56%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -41.46%.